What is Perkins Biomedical Services?
Headquartered in Bow, New Hampshire, Perkins Biomedical Services operates as a specialized technical partner for the healthcare and research industries. The company provides comprehensive repair, maintenance, and validation services for a wide array of laboratory instrumentation, including specialized Histology and Pathology equipment. By maintaining the precision of these critical assets, the firm enables clinical and academic laboratories to adhere to stringent regulatory standards while minimizing costly downtime.
The company's market position is defined by its technical expertise and its ability to service diverse equipment portfolios. In an era where laboratory throughput is increasingly tied to automated diagnostic capabilities, Perkins Biomedical Services serves as a vital link in the supply chain, ensuring that complex machinery remains operational and compliant with industry-wide quality benchmarks.
How much funding has Perkins Biomedical Services raised?
Perkins Biomedical Services has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Perkins Biomedical Services
PPP
Public-Private Partnership
What's next for Perkins Biomedical Services?
With the successful acquisition of $0, Perkins Biomedical Services is well-positioned to scale its service footprint and enhance its digital validation capabilities. The current late-stage funding context suggests a strategic pivot toward geographic expansion and the potential integration of predictive maintenance technologies. As the firm continues to mature, the focus will likely shift toward optimizing service delivery models and expanding its reach into larger hospital networks and private research conglomerates.
Investors are closely monitoring the company's ability to leverage this capital to capture a larger share of the laboratory services market. By deepening its technical bench and investing in proprietary diagnostic tools, Perkins Biomedical Services is poised to transition from a regional service provider to a dominant national player in the biomedical maintenance ecosystem.
